Application of Bilateral Sympathetic Nerve Cryoablation as a Bridge to Transplant for Refractory Ventricular…

Abstract

Background. The coronavirus disease 2019 (COVID-19) pandemic has decreased surgical activity, particularly in the field of oncology, because of the suspicion of a higher risk of COVID-19-related severe events. This study aimed to investigate the feasibility and safety of thoracic cancer surgery in the most severely affected European and Canadian regions during the COVID-19 pandemic.

Methods. The study investigators prospectively collected data on surgical procedures for malignant thoracic diseases from January 1 to April 30, 2020. The study included patients from 6 high-volume thoracic surgery departments: Nancy and Strasbourg (France), Freiburg (Germany), Milan and Turin (Italy), and Montreal (Canada). The centers involved in this research are all located in the most severely affected regions of those countries. An assessment of COVID-19-related symptoms, polymerase chain reaction (PCR)-confirmed COVID-19 infection, rates of hospital and intensive care unit admissions, and death was performed for each patient. Every deceased patient was tested for COVID-19 by PCR.

Results. In the study period, 731 patients who underwent 734 surgical procedures were included. In the whole cohort, 9 cases (1.2%) of COVID-19 were confirmed by PCR, including 5 in-hospital contaminants. Four patients (0.5%) needed readmission for oxygen requirements. In this subgroup, 2 patients (0.3%) needed intensive care unit and mechanical ventilatory support. The total number of deaths in the whole cohort was 22 (3%). A single death was related to COVID-19 (0.14%).

Conclusions. Maintaining surgical oncologic activity in the era of the COVID-19 pandemic seems safe and feasible, with very low postoperative morbidity or mortality. To continue to offer the best care to patients who do not have COVID-19, reports on other diseases are urgently needed.

A swine model of infarct-related reentrant ventricular tachycardia: Electroanatomic, magnetic resonance, and histopathological characterization
Cory Tschabrunn, Sébastien Roujol, Reza Nezafat +4
Heart Rhythm12 Oct 2026Peer-reviewedLicence not stated107 citedSystems & synthetic biologyHAL
Quantitative spatial connectomics of liver reveals a partially exposed sympathetic network that integrates multiple cell types across the portal tract
L. A. Noon, G. Casal, M. Soriano-Navarro +14
bioRxiv26 Oct 2026PreprintAll rights reservedFull textNeurosciencebioRxiv
Stressor-Selective Sympathetic Preganglionic Modules for Organ-Biased Control
S. Yamada, S. Uchida, M. Tsurutani +5
bioRxiv7 Sep 2026PreprintCC BY-NCFull textNeurosciencebioRxiv
Reversible, Sexually Dimorphic Sympathetic Aging: Distal Axon Withdrawal Shaped by Prepubertal Gonadal Influences
G. R. Pangilinan, S. Patil, F. Mires +10
bioRxiv3 Sep 2026PreprintCC BY-NC-NDFull textDevelopmental biologybioRxiv
A vagal-to-sympathetic reflex controls lung vascular leak
E. Robinson, E. M. Ibanez, B. Santibanez Ocampo +6
bioRxiv22 Oct 2026PreprintCC BYFull textNeurosciencebioRxiv

Cite

BibTeX RIS

BibTeX

@article{porta2026application,
  title = {{Application of Bilateral Sympathetic Nerve Cryoablation as a Bridge to Transplant for Refractory Ventricular Tachycardia}},
  author = {Marilina La Porta and Mathieu Echivard and Stéphane Renaud and Joseph Seitlinger},
  journal = {Annals of Thoracic Surgery Short Reports},
  year = {2026},
  month = oct,
  doi = {10.1016/j.atssr.2026.02.005},
  url = {https://hal.science/hal-05787732v1},
  note = {CC BY 4.0},
}

RIS

TY  - JOUR
TI  - Application of Bilateral Sympathetic Nerve Cryoablation as a Bridge to Transplant for Refractory Ventricular Tachycardia
AU  - Marilina La Porta
AU  - Mathieu Echivard
AU  - Stéphane Renaud
AU  - Joseph Seitlinger
PY  - 2026
DA  - 2026/10/08
JO  - Annals of Thoracic Surgery Short Reports
DO  - 10.1016/j.atssr.2026.02.005
UR  - https://hal.science/hal-05787732v1
AB  - Background. The coronavirus disease 2019 (COVID-19) pandemic has decreased surgical activity, particularly in the field of oncology, because of the suspicion of a higher risk of COVID-19-related severe events. This study aimed to investigate the feasibility and safety of thoracic cancer surgery in the most severely affected European and Canadian regions during the COVID-19 pandemic.  Methods. The study investigators prospectively collected data on surgical procedures for malignant thoracic diseases from January 1 to April 30, 2020. The study included patients from 6 high-volume thoracic surgery departments: Nancy and Strasbourg (France), Freiburg (Germany), Milan and Turin (Italy), and Montreal (Canada). The centers involved in this research are all located in the most severely affected regions of those countries. An assessment of COVID-19-related symptoms, polymerase chain reaction (PCR)-confirmed COVID-19 infection, rates of hospital and intensive care unit admissions, and death was performed for each patient. Every deceased patient was tested for COVID-19 by PCR.  Results. In the study period, 731 patients who underwent 734 surgical procedures were included. In the whole cohort, 9 cases (1.2%) of COVID-19 were confirmed by PCR, including 5 in-hospital contaminants. Four patients (0.5%) needed readmission for oxygen requirements. In this subgroup, 2 patients (0.3%) needed intensive care unit and mechanical ventilatory support. The total number of deaths in the whole cohort was 22 (3%). A single death was related to COVID-19 (0.14%).  Conclusions. Maintaining surgical oncologic activity in the era of the COVID-19 pandemic seems safe and feasible, with very low postoperative morbidity or mortality. To continue to offer the best care to patients who do not have COVID-19, reports on other diseases are urgently needed.
SN  - 2772-9931
SN  - 2772-9931
ER  -

Abstract

Related

Cite